Cargando…
Liver-spleen contrast standardization of gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging based on cross-calibration
BACKGROUND: Liver-spleen contrast in the hepatobiliary phase highly depends on the devices used for liver function tests. This study aimed to develop and validate a method to convert liver-spleen contrast data acquired with another device to reference liver-spleen contrast data, using the regression...
Autores principales: | Mori, Hiroshige, Akimoto, Satoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703119/ https://www.ncbi.nlm.nih.gov/pubmed/36465824 http://dx.doi.org/10.21037/qims-22-174 |
Ejemplares similares
-
Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging for evaluating fibrosis regression in chronic hepatitis C patients after direct-acting antiviral
por: Li, Xiao-He, et al.
Publicado: (2022) -
Contrast uptake in primary hepatic angiosarcoma on gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in the hepatobiliary phase
por: Hayashi, Manabu, et al.
Publicado: (2018) -
Consensus Report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance Imaging
por: Lee, Jeong Min, et al.
Publicado: (2011) -
Contrast-enhanced computed tomography plus gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging for gross classification of hepatocellular carcinoma
por: Chen, Chuang, et al.
Publicado: (2017) -
Impact of gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging on the prognosis of hepatocellular carcinoma after surgery
por: Shimada, Shingo, et al.
Publicado: (2020)